Anthra, Medeva Pharmaceuticals Inc. regulatory update

The FDA's Oncologic Drugs Advisory Committee voted 9-to-2 with one abstention to recommend approval

Read the full 147 word article

How to gain access

Continue reading with a
two-week free trial.